Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1852 to 1901 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRESENILIN-LIKE PROTEIN 1 (EC 3.4.99.-) (SPPL2B PROTEIN). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0331615\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.142049\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.233451133\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1853\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&&&&\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1854\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0274494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117581\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233450983\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRESENILIN-LIKE PROTEIN 2 (EC 3.4.99.-) (SPPL2A PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0275157\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233450982\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTP-BINDING NUCLEAR PROTEIN RAN (TC4) (RAN GTPASE) (ANDROGEN RECEPTOR- ASSOCIATED PROTEIN 24). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.46892\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.00865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233450327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RANP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0252313\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.108089\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233430784\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FCF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE II 19 KDA POLYPEPTIDE (EC 2.7.7.6) (RPB7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.222313\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.952373\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233430599\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR2G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1859\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.111248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.476584\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233427895\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GTPBP8\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1860\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.107268\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.459557\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233416094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR3GL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYMERASE (RNA) III (DNA DIRECTED) (32KD). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.130061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.557208\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233415529\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR3G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALANYL-TRNA SYNTHETASE (EC 6.1.1.7) (ALANINE--TRNA LIGASE) (ALARS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.321507\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.37786\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23333793\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AARS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.031449\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.134819\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233268308\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DOLK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THYMIDYLATE KINASE (EC 2.7.4.9) (DTMP KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.51096\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.19044\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233268202\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DTYMK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYNACTIN 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0462274\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.198227\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233204357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DCTN5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIPHOSPHOMEVALONATE DECARBOXYLASE (EC 4.1.1.33) (MEVALONATE PYROPHOSPHATE DECARBOXYLASE) (MEVALONATE (DIPHOSPHO)DECARBOXYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0688073\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.295201\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23308627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MVD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE [CARBOXYLATING] (EC 2.4.2.19) (QUINOLINATE PHOSPHORIBOSYLTRANSFERASE [DECARBOXYLATING]) (QAPRTASE) (QPRTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.133589\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.573452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232955853\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
QPRT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 4 (EC 1.14.13.8) (HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 4) (FMO 4) (DIMETHYLANILINE OXIDASE 4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0525547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.225696\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232856143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMO4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 1 (EC 1.14.13.8) (FETAL HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 1) (FMO 1) (DIMETHYLANILINE OXIDASE 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0533745\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.229226\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232846623\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CREATINE KINASE, B CHAIN (EC 2.7.3.2) (B-CK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.235164\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.00998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232840254\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CKB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 2 (EC 1.14.13.8) (PULMONARY FLAVIN-CONTAINING MONOOXYGENASE 2) (FMO 2) (DIMETHYLANILINE OXIDASE 2) (FMO 1B1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0540721\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.232231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232837563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMO2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASE REGULATORY SUBUNIT 4 (P26S4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.825694\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.54636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23282859\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 3 (EC 1.14.13.8) (HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 3) (FMO 3) (DIMETHYLANILINE OXIDASE 3) (FMO FORM 2) (FMO II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0571767\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.245601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232803205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMO3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CELLULAR MODULATOR OF IMMUNE RECOGNITION. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0341996\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.146922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232773853\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MARCH8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GOLGI COMPLEX ASSOCIATED PROTEIN 1; GOLGI RESIDENT PROTEIN GCP60; PERIPHERIAL BENZODIAZEPINE RECEPTOR ASSOCIATED PROTEIN; GOLGI PHOSPHOPROTEIN 1; PBR ASSOCIATED PROTEIN; PKA (RIALPHA)-ASSOCIATED PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.154668\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.664457\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232773528\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACBD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SARCOGLYCAN ZETA; ZETA-SARCOGLYCAN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0628075\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.269823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232772966\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SGCZ\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-SARCOGLYCAN (GAMMA-SG) (35 KDA DYSTROPHIN-ASSOCIATED GLYCOPROTEIN) (35DAG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0566858\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.243524\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232772951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SGCG\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DELTA-SARCOGLYCAN (SG-DELTA) (35 KDA DYSTROPHIN-ASSOCIATED GLYCOPROTEIN) (35DAG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0630725\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.270962\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232772492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SGCD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE 21 KDA PROTEOLIPID SUBUNIT (EC 3.6.3.14) (HATPL). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.465943\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.00171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23277248\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE 16 KDA PROTEOLIPID SUBUNIT (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.556589\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.39113\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232772371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0285481\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.122644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232772088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MARCH1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CREATINE KINASE, UBIQUITOUS MITOCHONDRIAL PRECURSOR (EC 2.7.3.2) (U- MTCK) (MIA-CK) (ACIDIC-TYPE MITOCHONDRIAL CREATINE KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.199469\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.856983\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232757243\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CREATINE KINASE, SARCOMERIC MITOCHONDRIAL PRECURSOR (EC 2.7.3.2) (S- MTCK) (MIB-CK) (BASIC-TYPE MITOCHONDRIAL CREATINE KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.197547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.848743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232752435\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CKMT2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 6 (EC 1.14.13.8) (FLAVIN-CONTAINING MONOOXYGENASE 6) (FMO 6) (DIMETHYLANILINE OXIDASE 6). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0627928\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.269788\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.232748677\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMO6P\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE FORMING] 5 (EC 1.14.13.8) (HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 5) (FMO 5) (DIMETHYLANILINE OXIDASE 5). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FMO5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
J DOMAIN PROTEIN C21ORF55. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.107843\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.463351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232745802\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C21orf55\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEPTIDYL PROLYL ISOMERASE H; CYCLOPHILIN H. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.039427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1694\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232744982\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPIH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRP18 PRE-MRNA PROCESSING FACTOR 18 HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.184055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.790803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232744438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRPF18\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1889\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIHYDROFOLATE REDUCTASE (EC 1.5.1.3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.241532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.03785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232723419\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STROMAL CELL-DERIVED FACTOR 2-LIKE PROTEIN 1 PRECURSOR (SDF2 LIKE PROTEIN 1) (PWP1-INTERACTING PROTEIN 8). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0221128\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0950179\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232722466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SDF2L1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STROMAL CELL-DERIVED FACTOR 2 PRECURSOR (SDF-2). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0275634\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.118439\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.23272233\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SDF2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THYMIDYLATE SYNTHASE (EC 2.1.1.45) (TS) (TSASE). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
TYMS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L3-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.34083\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.76236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232687649\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL3L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CREATINE KINASE, M CHAIN (EC 2.7.3.2) (M-CK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.219925\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.945419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232621726\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CKM\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MICROTUBULE-ASSOCIATED PROTEIN 4 (MAP 4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.036083\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155117\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232617959\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VAM6/VPS39-LIKE PROTEIN (HVAM6P). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.403209\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.73336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232616998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS39\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S13. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.3472\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.49288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232570602\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRANSLATION INITIATION FACTOR IF-2, MITOCHONDRIAL PRECURSOR (IF-2MT) (IF-2(MT)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.416108\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.78993\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232471661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTIF2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L17 (L23). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.63284\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.72242\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232454948\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ENDOTHELIAL-DERIVED GENE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0600275\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.258242\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232446697\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MED28\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRP5 PROTEIN HOMOLOG (PROGRAMMED CELL DEATH PROTEIN 11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.132484\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.570026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.232417469\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDCD11\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/